The beneficial effects of combining Chk and Wee1 inhibitors have been demonstrated in BRAF mutant and wild-type melanoma cells, as well as in other human tumor cell lines [28, 29, 31, 32]. The gene discussed is WEE1; the disease is neoplasm.